Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers
Oncology Reviews · 14.04.2025 · 19
DOI: 10.3389/or.2025.1581856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reviews, online erschienen am 14.04.2025. Verfasst von Qingqing Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine, Weifang People's Hospital, Weifang, Shandong, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The high incidence and mortality rates associated with gastrointestinal cancers represent a significant global health challenge. In recent years, CAR T cell therapy has emerged as a promising immunotherapeutic approach, demonstrating favorable clinical outcomes. However, the application of traditional CAR T cell therapy in gastrointestinal cancers faces numerous challenges, including the suppressive tumor microenvironment and limitations in anti-tumor efficacy. The application of engineered bacteria offers a novel strategy to enhance CAR T cell therapy by modulating the tumor microenvironment and boosting immune responses, potentially leading to improved therapeutic outcomes. This review synthesizes the current research advancements related to engineered bacteria-assisted CAR T cell therapy in gastrointestinal cancers, exploring its underlying mechanisms, clinical applications, and future developmental directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Medicine, Weifang People's Hospital, Weifang, Shandong, China.
- Department of Gastroenterology, Weifang People's Hospital, Weifang, Shandong, China.
- The Third Department of Geriatrics, Weifang People's Hospital, Weifang, Shandong, China.
- Hospital Preparation Center, Weifang People's Hospital, Weifang, Shandong, China.
Zitieren
APA
Zhang, Q., Song, X., Liu, J., & Zhou, X. (2025). Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers. Oncology Reviews, 19. https://doi.org/10.3389/or.2025.1581856
Vancouver
Zhang Q, Song X, Liu J, Zhou X. Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers. Oncology Reviews. 2025;19. doi:10.3389/or.2025.1581856
BibTeX
@article{Zhang2025,
author = {Zhang, Qingqing and Song, Xiao and Liu, Junhong and Zhou, Xuejiao},
title = {Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers},
journal = {Oncology Reviews},
year = {2025},
volume = {19},
doi = {10.3389/or.2025.1581856}
}
EUVIMED